Monique Minnema, MD, PhD is a hematologist at the Department of Hematology in University Medical Center (UMC) Utrecht in Utrecht, Netherlands. She specializes in the diagnosis and treatment of B cell malignancies, especially plasma cell dyscrasias, like multiple myeloma, AL amyloidosis, and Waldenström’s Macroglobulinemia. She is the medical head of the hematology research team and the biobank LML. She is a member of the HOVON working parties for multiple myeloma, lymphoma, and vice-chair of the Lunenburg Lymphoma consortium (LLPC) for phase I/II studies. Dr. Minnema is the principal investigator of the HOVON 104 trial for patients with AL amyloidosis, the clinical studies with the monoclonal antibody daratumumab in multiple myeloma and AL amyloidosis and CAR T-cell treatment in relapsed Non-Hodgkin's Lymphoma. Prof. Dr. Minnema is the chair for the national guidelines for treatment of AL amyloidosis and diagnostics in plasma cell dyscrasias.